Venturing into the no-man's land of the retina in Parkinson's disease

Movement Disorders

Volumn 29, Issue 1, 2014, Pages 15-22

  Bodis Wollner, Ivan ^a,b,c   Miri, Shahnaz ^a   Glazman, Sofya ^a  

^a Downstate Health Sciences University   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c SUNY EYE INSTITUTE   (United States)

Author keywords

Foveola; Macula; Optical coherence tomography; Parkinson's disease; Retinal nerve fiber layer

Indexed keywords

CONTRAST SENSITIVITY; DENDRITE; DIAGNOSTIC VALUE; DISEASE SEVERITY; ECHOGRAPHY; ELECTRORETINOGRAPHY; HISTOPATHOLOGY; HUMAN; MACULAR THICKNESS; MULTIPLE SCLEROSIS; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA EXAMINATION; RETINA MACULA LUTEA; RETINAL THICKNESS; REVIEW; TEMPORAL LOBE; VISUAL IMPAIRMENT;

FOVEOLA; MACULA; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON'S DISEASE; RETINAL NERVE FIBER LAYER;

HUMANS; PARKINSON DISEASE; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84892937835     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25741     Document Type: Review

References (51)

1. Bodis-Wollner I. Retinopathy in Parkinson disease. J Neural Transm 2009;116:1493-1501.
2. Bagci AM, Shahidi M, Ansari R, Blair M, Blair NP, Zelkha R. Thickness profiles of retinal layers by optical coherence tomography image segmentation. Am J Ophthalmol 2008;146:679-687.
3. Smolyaninov II, Elliott J, Zayats AV, Davis CC. Far-field optical microscopy with a nanometer-scale resolution based on the in-plane image magnification by surface plasmon polaritons. Phys Rev Lett 2005;94:057401.
4. Friedenwald H. The history of the invention and of the development of the ophthalmoscope. JAMA 1902;38:549-552.
5. Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I. Interocular asymmetry of foveal thickness in Parkinson disease [serial online]. J Ophthalmol 2012;2012:728457.
6. Keeler CR. A brief history of the ophthalmoscope. Optom Pract 2003;4:137-145.
7. Jonas JB, Dichtl A. Evaluation of the retinal nerve fiber layer. Surv Ophthalmol 1996;40:369-378.
8. Jonas JB, Budde WM, Panda-Jonas S. Ophtalmoscopic evaluation of the optic nerve head. Surv Ophthalmol 1999;43:293-320.
9. Kopsch F, Rauber AA. Rauber-Kopsch Lehrbuch und Atlas der Anatomie des Menschen. Stuttgart, Germany: Thieme Medical Publishers; 1940.
10. Kolb H, Linberg KA, Fisher SK. Neurons of the human retina: a Golgi study. J Comp Neurol 1992;318:147-187.
11. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181.
12. Fujimoto JG. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol 2003;21:1361-1367.
13. Zernike F. Observing the phases of light waves. Science 1948;107:463-463.
14. de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, Bouma BE. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett 2003;28:2067-2069.
15. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 2004;44:2793-2797.
16. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008;1116:137-146.
17. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 2010;21:24-29.
18. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 2010;4:1427-1432.
19. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 2011;17:431-436.
20. Tsironi EE, Dastiridou A, Katsanos A, et al. Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease [serial online]. BMC Ophthalmol 2012;12:54.
21. Albrecht P, Muller AK, Sudmeyer M, et al. Optical coherence tomography in parkinsonian syndromes [serial online]. PLoS One 2012;7:e34891.
22. Garcia-Martin E, Satue M, Fuertes I, et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology 2012;119:2161-2167.
23. Rohani M, Langroodi AS, Ghourchian S, Falavarjani KG, Soudi R, Shahidi G. Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease. Neurol Sci 2013;34:689-693.
24. Kirbas S, Turkyilmaz K, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 2013;33:62-65.
25. 25#.Garcia-Martin E, Satue M, Fuertes I, et al. Optical coherence tomography and electrophysiology to evaluate Parkinson disease severity. Acta Ophthalmol In press.
26. Sen A, Tugcu B, Coskun C, Ekinci C, Nacaroglu SA. Effects of levodopa on retina in Parkinson disease [published online 3 July 2013]. Eur J Ophthalmol 2013.
27. La Morgia C, Barboni P, Rizzo G, et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 2013;20:198-201.
28. Satue M, Garcia-Martin E, Fuertes I, et al. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients. Eye (Lond) 2013;27:507-514.
29. Moreno-Ramos T, Benito-Leon J, Villarejo A, Bermejo-Pareja F. Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. J Alzheimers Dis 2013;34:659-664.
30. Hajee M, March W, Lazzaro D, Wolintz A, Shrier E, Glazman S, Bodis-Wollner I. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009;127:737-741.
31. Cubo E, Tedejo RP, Rodriguez Mendez V, Lopez Pena MJ, Trejo Gabriel Y Galan JM. Retinal thickness in Parkinson's disease and essential tremor. Mov Disord 2010;25:2461-2462.
32. Adam C, Shrier E, Bodis-Wollner, I, Ding Y, Glazman S. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 2013;33:137-142.
33. Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I. Remodeling of the fovea in Parkinson disease. J Neural Transm 2013;120:745-753.
34. Lee JY, Kim JM, Ahn J, Kim HJ, Jeon BS, Kim TW. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's disease. Mov Disord 2014;29:61-67.
35. Yuodelis C, Hendrickson A. A qualitative and quantitative analysis of the human fovea during development. Vis Res 1986;26:847-855.
36. Swanson EA, Izatt JA, Hee MR, et al. In vivo retinal imaging by optical coherence tomography. Opt Lett 1993;18:1864-1866.
37. Cubo E, Lopez-Pena MJ, Perez-Gil O, Diez-Feijoo E, Garcia-Gutierrez P, Perez-Mariscal N, Araus-Gonzalez E. Diagnostic accuracy of morphological and functional retinal impairment in Parkinson's disease [abstract]. Mov Disord 2013;28(suppl 1):206.
38. Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 2003;135:513-520.
39. DeLeon-Ortega J, Carroll KE, Arthur SN, Girkin CA. Correlations between retinal nerve fiber layer and visual field in eyes with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2007;143:288-294.
40. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391.
41. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007;69:1603-1609.
42. Nowacka B, Lubinski W, Karczewicz D. Ophthalmological and electrophysiological features of Parkinson's disease. Klin Oczna 2010;112(7-9):247-252.
43. Cuenca N, Herrero MT, Angulo A, et al. Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease. J Comp Neurol 2005;493:261-273.
44. Hood DC, Frishman LJ, Saszik S, Viswanathan S. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 2002;43:1673-1685.
45. Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, Gabrieli JDE. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004;63:1409-1416.
46. Pfeiffer RF, Bodis-Wollner I. Charles Bonnet syndrome. J Am Geriatr Soc 1996;44:1128-1129.
47. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 2005;20:130-140.
48. Zernike F. How I discovered phase contrast. Science 1955;121:345-349.
49. Johnson SA. Phase contrast microscopy. In: Shaked NT, Zalevsky Z, Satterwhite LL, editors. Biomedical Optical Phase Microscopy and Nanoscopy. New York: Academic Press; 2012:3-18.
50. Joo C, Akkin T, Cense B, Park BH, de Boer JF. Spectral-domain optical coherence phase microscopy for quantitative phase-contrast imaging. Opt Lett 2005;30:2131-2133.
51. Tian T, Zhu XH, Liu YH. Potential role of retina as a biomarker for progression of Parkinson's disease. Int J Ophthalmol 2011;4:433-438.